Your institution may have access to this item. Find your institution then sign in to continue.
Title
Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight without Risk of Hypoglycemia in Patients With Type 2 Diabetes.